Plaintiffs seek to attach assets of compounding company linked to meningitis
In a two-hour hearing, lawyers battled over whether a federal judge should order the attachment of up to $461 million in assets belonging to New England Compounding Pharmacy Inc.which is primarily linked to a fungal meningitis outbreak that caused 34 deathsand other related companies and individuals.
This premium content is reserved for National Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now